Clinical Trials Logo

Substance-Related Disorders clinical trials

View clinical trials related to Substance-Related Disorders.

Filter by:

NCT ID: NCT05818384 Recruiting - Sedentary Behavior Clinical Trials

Wakaya: Rising Up for Choctaw Youth Health

Wakaya
Start date: April 28, 2023
Phase: N/A
Study type: Interventional

Investigators will conduct a two-group randomized waitlist-control trial to assess the efficacy of the Wakaya: Rising Up for Choctaw Youth Health program on improving physical activity, reducing sedentary behaviors and improving healthful eating habits as well as delaying or reducing alcohol, tobacco and other drug use. Wakaya is an experiential, outdoor, nature-based program grounded in Choctaw values. It is a multi-level intervention that increases individual motivation and leadership skills to make healthy behavioral choices for behavior and exercise.

NCT ID: NCT05816083 Not yet recruiting - HIV Infections Clinical Trials

Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young People

Start date: October 15, 2024
Phase: N/A
Study type: Interventional

This is a multi-phased study, funded through a National Institute on Drug Abuse (NIDA) K24 grant that aims to ultimately refine a virtual reality tool through qualitative and quantitative research targeting HIV and substance abuse risk behavior among at-risk young people who have experienced psychosocial trauma. Participants eligible for this study include young men who have sex with men (YMSM) and adolescents with substance use disorder (SUD) between the ages of 13 - 25 and have experienced at least one traumatic event in their lifetime. Frontline healthcare workers who work within these populations are eligible for the study as well.

NCT ID: NCT05814575 Recruiting - Pregnancy Related Clinical Trials

NEXUS - Next Generation Health Through 2D & 3D Fetal UltraSound; Building Connections to Support Maternal-fetal Health

NEXUS
Start date: June 8, 2023
Phase: N/A
Study type: Interventional

This exploratory study brings together an interprofessional team, novel tools, and innovative, community-driven care delivery approaches to improve health equity among mother-infant dyads impacted by substance use disorder and high risk for poor health outcomes. This study will test a community-informed and community-based intervention using a fetal ultrasound protocol, motivational interviewing techniques, strength-based education, and healthcare coordination strategies to reduce health disparities faced by women and their children.

NCT ID: NCT05812469 Completed - Clinical trials for Alcohol Use Disorder

A Psychoeducational Intervention for Brain Awareness, Metacognition, Self-efficacy and Treatment Motivation

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to examine the effect of brain awareness intervention on metacognition, self-efficacy and treatment motivation in patients with alcohol and substance use disorders. It is an experimentally designed study with a randomized control group and repeated measurements (pre-test, mid-test, post-test).

NCT ID: NCT05812131 Not yet recruiting - PTSD Clinical Trials

COPEWeb Training for Providers

COPEWeb
Start date: August 1, 2024
Phase: N/A
Study type: Interventional

PTSD and substance use disorders (SUD) are two of the most common and debilitating mental health conditions afflicting military Veterans. PTSD and SUD frequently co-occur and are associated with poorer treatment outcomes. The investigators' team developed a trauma-focused intervention, Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE), which is identified by the VA as a gold standard of behavioral healthcare. However, a critical barrier to ensuring that Veterans with co-occurring PTSD/SUD receive evidence-based treatment is a lack of provider training. This project directly addresses this critical gap by developing a new web-based training program for providers (COPEWeb).

NCT ID: NCT05806840 Active, not recruiting - Substance Use Clinical Trials

Rapid Adaptation to Prevent Drug Use

RAPD
Start date: September 6, 2023
Phase: N/A
Study type: Interventional

Using a 2-group, mixed method cluster randomized trial design, this study will compare standard implementation versus RAPD implementation strategy in Michigan Middle Schools

NCT ID: NCT05803044 Not yet recruiting - Drug Addiction Clinical Trials

Importance of Drug User Detection

Start date: May 1, 2023
Phase:
Study type: Observational

1. Identify the illicit drugs (morphine, cannabinoids, benzodiazepines, barbiturates, tramadol, cocaine, amphetamine, alcohol, synthetic cannabinoids). 2. Identify illicit drug users in patients who admitted in Assiut University Hospitals undergoing emergency operation and their percent among all patients admitted for emergency operation, for proper selection of anaesthetic agents and proper care before, during and after operations. 3. Compare between addict and non addict in using suitable anaesthetic agents and doses - period of anaesthesia- period of recovery- complications. 4. Compare between addict and non addict patients in :( vital signs before, during and after operation by using anaesthetic chart). 5. Identify the importance of using drug abuse detection as a routine lab work before urgent operations.

NCT ID: NCT05799209 Recruiting - Clinical trials for Amphetamine-Type Substance Use Disorder

Floatation-REST in Methamphetamine Use Disorder: A Pilot Study

Start date: March 15, 2022
Phase: N/A
Study type: Interventional

This early-stage trial aims to examine the feasibility, tolerability, and safety of Floatation-REST (Reduced Environmental Stimulation Therapy) or an active comparison condition in 50 individuals receiving treatment for Amphetamine-Type Substance Use Disorder.

NCT ID: NCT05794984 Completed - Telemedicine Clinical Trials

Telemedicine and Social Media for People Who Inject Drugs (PWID) in Greece

Start date: May 2, 2023
Phase:
Study type: Observational

The current study seeks to address questions regarding internet and social media usage as well as telemedicine concept and knowledge, by conducting targeted focus group discussions (FGDs) and administering cross-sectional questionnaires among PWID in Greece. Further parameters, such as perceptions for high-quality healthcare access, confidentiality, privacy, and security, will also be explored.

NCT ID: NCT05794646 Recruiting - Clinical trials for Substance Use Disorders

Community Intervention to Eliminate HCV Among People Who Use Drugs.

ICONE2
Start date: October 2, 2023
Phase: N/A
Study type: Interventional

The goal of this interventional study is twofold with the evaluation of the feasibility and potential usefulness of an implementation strategy, and the efficiency of a community-based model of mass screening and immediate treatment of hepatitis C among People Who Use Drugs (PWUD) in three major cities in mainland France (Paris, Lyon and Marseille) and in one overseas city (Fort-de-France). The investigators will also describe the psychological and infectious comorbidities of drug users, determine the stages of the HCV (Hepatitis C Virus), HBV (Hepatitis B Virus), HIV (Human Immunodeficiency Virus) care cascade, and analyze the factors associated with HCV treatment failure. A qualitative study will investigate the acceptability of the RDS model. Participants will be screened in an out of bound research center and receive appropriate treatment for infectious, addictological and psychiatric troubles. They will receive coupons to give to their peers for them to participate in the study. Researchers will also compare the acceptability of referral to psychiatric care directly at the research site (intervention group) with that of referral directly to a city facility (control group).